Clinical practice guidelines in infectious diseases

Netherlands Journal of Medicine

Volumn 60, Issue 9, 2002, Pages 343-348

  Peetermans, Willy E ^a   Ramaekers, D ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Belgian Center for Evidence Based Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CONSENSUS DEVELOPMENT; CONTINUING EDUCATION; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL PROFESSION; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; INFECTION;

HUMANS; INFECTION; PRACTICE GUIDELINES;

EID: 0036825158     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Committee to Advise the Public Health Service on Clinical Practice Guidelines. Institute of Medicine. In: Field MJ, Lohr KN, eds. Clinical practice guidelines: directions of a new program. Washington DC: National Academy Press, 1990.
2. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
3. Thomson R, Lavender M, Madhok R. How to ensure that guidelines are effective. Br Med J 1995;311:237-42.
4. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations and harms of clinical guidelines. Br Med J 1999;318:527-30.
5. Brown EM. Guidelines for antibiotic usage in hospitals. J Antimicrob Chemother 2002;49:587-92.
6. Struelens MJ, Peetermans WE. The antimicrobial resistance crisis in hospitals calls for multidisciplinary mobilization. Acta Clin Belg 1999;54:2-6.
7. Kasteren MEE van, Wijnands MJA, Stobberingh EE, Janknegt R, Verbrugh HA, Meer JWM van der. Optimaliseren van het antibioticabeleid in Nederland. I. De Stichting Werkgroep Antibioticabeleid (SWAB). Ned Tijdschr Geneesk 1998;142:949-51.
8. GDEPIH-GOSPIZ Working Party. GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistant bacteria in hospitals. Acta Clin Belg 1999;54:15-6.
9. Goldman DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-40.
10. Shlaes DM, Gerding DN, John FJ, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin infect Dis 1997;25:584-99.
11. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J 1996;312:71-2.
12. Hurwitz B. Legal and political considerations of clinical practice guidelines. Br Med J 1999;318:661-4.
13. Berger JT, Rosner F. The ethics of practice guidelines. Arch Intern Med 1996;156:2051-6.
14. Gevers S. Legal issues in the development and use of clinical practice guidelines. Med Law 2001;20:183-91.
15. Miller J, Petrie J. Development of practice guidelines. Lancet 2000;355:82-3
16. Sniderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet 1999;354:327-30.
17. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000;355:103-6.
18. Lacasse Y, Ferreira I, Brooks D, Newman T, Goldstein RS. Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease. Arch Intern Med 2001;161:69-74.
19. Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assessment 1998;2(3). Http://www.hta.nhsweb.nhs.uk/.
20. Jones J, Hunter D. Qualitative Research: Consensus methods for medical and health services research. Br Med J 1995;311:376-80.
21. Edwards JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe Candidal infections. Clin Infect Dis 1997;25:43-59.
22. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. Br Med J 1999;318:593-6.
23. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001;32:851-4.
24. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-5.
25. Nagler J, Peetermans W, Goossens H, Struelens M. National committee for the coordination of antibiotic policy in Belgium: the next step in the fight against antimicrobial resistance. Acta Clin Belg 1999;54:319-20.
26. Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Using clinical guidelines. Br Med J 1999;318:728-30.
27. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-5.
28. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 1990;263:549-56.
29. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-31.
30. Gross PA, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage. Med Care 2001;39:8(suppl 2):S55-S69.
31. Goossens H, Peetermans W, Sion JP, Bossens M. Perioperatief antibiotisch profylaxebeleid in de Belgische ziekenhuizen 'evidence-based' door afgestemd vergoedingensysteem. Ned Tijdschr Geneesk 2001;145:1773-7.
32. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines. A framework for improvement. JAMA 1999;282:1458-65.
33. Solomon M, Raveh D, Schlesinger Y, Yinnon AM. Assessment of knowledge of guidelines for the prevention of infective endocarditis amongst clinicians in a teaching hospital. J Hosp Infect 2000;45:311-7.
34. Halm EA, Atlas SJ, Borowsky LH, et al. Understanding physician adherence with a pneumonia practice guideline. Arch Intern Med 2000;160:98-104.
35. Formoso G, Liberati A, Magrini N. Practice guidelines: useful and 'participative' method? Arch Intern Med 2001;161:2037-42.
36. Hayward RSA, Guyatt GH, Moore KA, McKibbon KA, Carter AO. Canadian physicians attitudes about and preferences regarding clinical practice guidelines. Can Med Assoc J 1997;156:1715-23.
37. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect DiS 2001;32:728-41.
38. Gyssens IC. How to optimize prescription of antimicrobial drugs. Acta Clin Belg 1999;54:7-12.
39. Solomon DH, Houten L van, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001;161:1897-902.
40. Nathwani D, Davey P, France AJ, Philips G, Orange G, Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. Q J Med 1996;89:789-97.
41. Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.
42. Byl B, Clevenbergh Ph, Jacobs F, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999;29:60-6.
43. Keuleyan E, Gould IM. Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European study group on antibiotic policy (ESCAP), subgroup III. Clin Microbiol Infect 2001;7(suppl 6):S16-S21.